BMJ  2006;332:455-459 (25 February), doi:10.1136/bmj.38740.439664.DE (published 1 February 2006)

Research

Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study

¹ Inserm, E361, Pathologies of the Nervous System, 34093 Montpellier, France

Abstract

Objective To assess the potential of anticholinergic drugs as a cause of non-degenerative mild cognitive impairment in elderly people.

Design Longitudinal cohort study.

Setting 63 randomly selected general practices in the Montpellier region of southern France.

Participants 372 people aged > 60 years without dementia at recruitment.

Main outcome measures Anticholinergic burden from drug use, cognitive examination, and neurological assessment.

Results 9.2% of subjects continuously used anticholinergic drugs during the year before cognitive assessment. Compared with non-users, they had poorer performance on reaction time, attention, delayed non-verbal memory, narrative recall, visuospatial construction, and language tasks but not on tasks of reasoning, immediate and delayed recall of wordlists, and implicit memory. Eighty per cent of the continuous users were classified as having mild cognitive impairment compared with 35% of non-users, and anticholinergic drug use was a strong predictor of mild cognitive impairment (odds ratio 5.12, P = 0.001). No difference was found between users and non-users in risk of developing dementia at follow-up after eight years.

Conclusions Elderly people taking anticholinergic drugs had significant deficits in cognitive functioning and were highly likely to be classified as mildly cognitively impaired, although not at increased risk for dementia. Doctors should assess current use of anticholinergic drugs in elderly people with mild cognitive impairment before considering administration of acetylcholinesterase inhibitors.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Delirium in older people

John Young and Sharon K Inouye
BMJ 2007 334: 842-846. [Extract] [Full Text] [PDF]

Anticholinergic drugs may cause cognitive decline in elderly people
BMJ 2006 332: 0. [Full Text]

This article has been cited by other articles:

• Weston, A. L., Weinstein, A. M., Barton, C., Yaffe, K. (2009). Potentially Inappropriate Medication Use in Older Adults With Mild Cognitive Impairment. J Gerontol A Biol Sci Med Sci 0: glp158v1-glp158 [Abstract] [Full text]  
• Nishtala, P. S., Fois, R. A., McLachlan, A. J., Bell, J. S., Kelly, P. J., Chen, T. F. (2009). Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People. J Clin Pharmacol 49: 1176-1184 [Abstract] [Full text]  
• Carriere, I., Fourrier-Reglat, A., Dartigues, J.-F., Rouaud, O., Pasquier, F., Ritchie, K., Ancelin, M.-L. (2009). Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General Population: The 3-City Study. Arch Intern Med 169: 1317-1324 [Abstract] [Full text]  
• Artero, S, Ancelin, M-L, Portet, F, Dupuy, A, Berr, C, Dartigues, J-F, Tzourio, C, Rouaud, O, Poncet, M, Pasquier, F, Auriacombe, S, Touchon, J, Ritchie, K (2008). Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J. Neurol. Neurosurg. Psychiatry 79: 979-984 [Abstract] [Full text]  
• Maruyama, S., Tsukada, H., Nishiyama, S., Kakiuchi, T., Fukumoto, D., Oku, N., Yamada, S. (2008). In Vivo Quantitative Autoradiographic Analysis of Brain Muscarinic Receptor Occupancy by Antimuscarinic Agents for Overactive Bladder Treatment. J. Pharmacol. Exp. Ther. 325: 774-781 [Abstract] [Full text]  
• Rudolph, J. L., Salow, M. J., Angelini, M. C., McGlinchey, R. E. (2008). The Anticholinergic Risk Scale and Anticholinergic Adverse Effects in Older Persons. Arch Intern Med 168: 508-513 [Abstract] [Full text]  
• Ritchie, K., Carriere, I., de Mendonca, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., Ancelin, M. L. (2007). The neuroprotective effects of caffeine: A prospective population study (the Three City Study). Neurology 69: 536-545 [Abstract] [Full text]  
• Young, J., Inouye, S. K (2007). Delirium in older people. BMJ 334: 842-846 [Full text]  
• Portet, F, Ousset, P J, Visser, P J, Frisoni, G B, Nobili, F, Scheltens, P., Vellas, B, Touchon, J, the MCI Working Group of the European Consortium o, (2006). Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J. Neurol. Neurosurg. Psychiatry 77: 714-718 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Calculating "Anticholinergic Burden"

Ronald P Fisher
bmj.com, 2 Feb 2006 [Full text]

Causes for cognitive impairment other than anti-cholinergics

S S RAIZ M ISMAIL
bmj.com, 21 Feb 2006 [Full text]

The use of anticholinergic drugs in psychiatry

AK Al-Sheikhli
bmj.com, 25 Feb 2006 [Full text]

Possible bias and confounding in the relation between mild cognitive impairment and use of anticholinergic drugs

Barbara C van Munster, et al.
bmj.com, 28 Feb 2006 [Full text]

APOE Gene Polymorphism and Drug-Induced Cognitive Toxicity

Nunzio Pomara, et al.
bmj.com, 3 Mar 2006 [Full text]

Judicious use of psychotropics in elderly population

Indrapal Singh, et al.
bmj.com, 9 Mar 2006 [Full text]

Anticholinergic drug use is a significant predictor of mild cognitive impairment

Marie L. Ancelin, et al.
bmj.com, 7 Mar 2006 [Full text]

variability in the literature on outcome measures used in mild cognitive impairment

Bharathi Balasundaram
bmj.com, 14 Nov 2006 [Full text]

Online poll

Find out more on doc2doc >>